Klein, K.
Kendel, F.
Schüürhuis, S.
Neumann, K.
Kowalski, C.
Thomas, P.
Reinhold, T.
Felbor, U.
Stegen, S.
Schmid, C.
Mehrhof, N.
Asmussen, S.
Diel, F.
Feufel, M.A.
Speiser, D.
Funding for this research was provided by:
Gemeinsame Bundesausschuss (01NVF20002)
Charité - Universitätsmedizin Berlin
Article History
Received: 29 November 2024
Accepted: 9 May 2025
First Online: 2 June 2025
Declarations
:
: The study is performed in accordance with the Helsinki Declaration and ICH guidelines to Good Clinical Practice (GCP). The approval of the ethics committee was obtained from the Charité as a first vote on 19 December 2022 (EA4/160/44), from the ethics committee of the UM Greifswald as a second vote on 5 May 2023 (BB-031–23) and as a third vote from the Brandenburg State Medical Association on 20 June 2023 (2023–66-BO). The consent forms (German) are attached to this protocol as additional file 1. It has been individually adapted for all participating study sites.
: The consent forms (German) are attached to this protocol as additional file 1. It has been individually adapted for all participating study sites.
: Katharina Klein and Christoph Kowalski are employees of the non-profit German Cancer Society, which is one of the institutions in charge of the certification system of cancer centres. All other authors declare that they have no competing interests.